Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01668563 · ClinicalTrials.gov registry record · NA
International Subarachnoid Aneurysm Trial II
A NA study of Intracranial Hemorrhage Ruptured Aneurysm, sponsored by Centre hospitalier de l'Université de Montréal (CHUM).
- Active
- Registry status
- NA
- Development phase
- 1,724
- Enrollment target
- 6
- Study locations
NCT01668563: Active NA study of Intracranial Hemorrhage Ruptured Aneurysm, sponsored by Centre hospitalier de l'Université de Montréal (CHUM).
NCT01668563 is a NA study of Intracranial Hemorrhage Ruptured Aneurysm that is active but no longer recruiting, run by Centre hospitalier de l'Université de Montréal (CHUM). The registered enrollment target is 1,724 participants, above the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (23% higher). The trial reports 6 study locations across 4 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01668563, a NA study of Intracranial Hemorrhage Ruptured Aneurysm, is active but no longer recruiting, sponsored by Centre hospitalier de l'Université de Montréal (CHUM).
- ACTIVE NOT RECRUITING
- Registry status
- NA
- Development phase
- 1,724 participants
- Enrollment target
- 6
- Study locations
Study Summary
The purpose of this study is to compare the clinical outcome of surgical clipping and endovascular coiling for ruptured intracranial aneurysms not included in the original ISAT Study.
Conditions Studied
Interventions
- PROCEDURE surgical management
- PROCEDURE Endovascular management
Study Locations (6)
Alberta
- Foothills Medical Centre - Calgary
- University of Alberta Hospital - Edmonton
Other
- Vall d'Hebron Hospital - Barcelona
- University of Valladolid - Valladolid
New York
- Montefiore Medical Center - The Bronx
Quebec
- Centre Hospitalier de l'Université de Montréal - Hôpital Notre Dame - Montreal
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1,724 participants |
| Start Date | 2012-11-12 |
| Est. Completion | 2024-12 |
| Phase | NA |
What the registry record for NCT01668563 still lists
NCT01668563 is an interventional study that assigns participants to a tested intervention. Its 1,724 participants enrollment target places it among the larger protocols in the corpus, above the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (23% higher).
The record links to 1 condition, with Intracranial Hemorrhage Ruptured Aneurysm appearing as the primary indexed condition, and to 2 interventions - of which surgical management is the first listed.
NCT01668563 lists 6 locations in 4 states (Alberta, Other, New York).
Frequently Asked Questions
What is clinical trial NCT01668563 about?
NCT01668563 is a clinical study titled "International Subarachnoid Aneurysm Trial II". The purpose of this study is to compare the clinical outcome of surgical clipping and endovascular coiling for ruptured intracranial aneurysms not included in the original ISAT Study.
What is the current status of trial NCT01668563?
This trial is currently active not recruiting. It is a NA study. The enrollment target is 1,724 participants. The study started on 2012-11-12. Estimated completion is 2024-12.
What conditions does trial NCT01668563 study?
This clinical trial studies the following conditions: Intracranial Hemorrhage Ruptured Aneurysm.
What interventions are being tested in trial NCT01668563?
The interventions under investigation include: surgical management (PROCEDURE), Endovascular management (PROCEDURE).
Who is sponsoring clinical trial NCT01668563?
This trial is sponsored by Centre hospitalier de l'Université de Montréal (CHUM), which has 10 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT01668563 being conducted?
This trial has 6 study locations across New York, Alberta, Quebec. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT01668563's enrollment target sits among peer trials
1,724 62nd of 2000 higher than 1,939 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT06898034 · 1,725 participants
Postpartum Ultrasound Evaluation to Assess Risk of Hemorrhage
- NCT06413420 · 1,731 participants
SUNOSI® (Solriamfetol) Pregnancy Registry
- NCT04291612 · 1,715 participants
Observational Study of Women With Endometrial Cancer Who Receive the Standard Treatment for Their Disease
- NCT05303636 · 1,710 participants · Phase 4
LF111 or Drospirenone Chew vs Non-hormonal Contraceptive Methods on Bone Mineral Density in Adolescent and Adult Women
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI